Parameterization of the CHARMM force field for divalent cations (Ca2+/Be2+) binding to anionic lipids with isothermal titration calorimetry.

Authors

Jessica Bodosa, Sergei Sukharev, Jeffery B Klauda

Published in

The Journal of chemical physics. Volume 165. Issue 12. Sep 28, 2026.

Abstract

Beryllium toxicity manifests as a rare lung disease, berylliosis, characterized by persistent granulomas. Studies indicate that, in the presence of Be2+, macrophage phagocytosis is markedly reduced, potentially hindering the removal of apoptotic cells. Although the exact mechanism by which Be2+ ions reduce phagocytosis is unclear, one hypothesis suggests that these small ions outcompete Ca2+ in critical ion-lipid and lipid-protein interactions mediating lipid recognition. To explore these interactions at the atomic level using molecular dynamics (MD), we aim to improve existing MD force fields for Be2+-lipid interactions. Based on thermodynamic binding data from isothermal titration calorimetry, we have updated the CHARMM36 force field to describe interactions of Be2+ and Ca2+ with palmitoyl-oleyl phosphatidic acid (POPA), palmitoyl-oleyl phosphatidyl glycerol (POPG), and small-molecule mimics of their headgroups. Our results show that the original force field overestimated the binding affinity of Be2+ for POPA and POPG by a factor of 4-6. The revised parameters differentiate how ions bind to phosphate groups in monoester and diester forms. We describe the interrelationships among L-J parameters, ion coordination, and binding energies, highlighting the significant role of water in Be2+-ion interactions. This work provides updated CHARMM36 force-field parameters for Be2+ and Ca2+, improving the accuracy of their interactions with potent signaling lipids, POPA and POPG, and better reflecting physiological behavior. Be2+ exhibits a stronger binding tendency, which can displace Ca2+ from its sites and hinder lipid recognition and phagocytosis.

PMID:
42775765
Bibliographic data and abstract were imported from PubMed on 23 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.